title: Succinylcholine for Emergency Airway Rescue in Class B Ambulatory Facilities: The Society for Ambulatory Anesthesia Position Statement.
abstract: Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedative-hypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine-triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.
authors.affiliation: From the *Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical School, Dallas, Texas; †Nova Anesthesia, Villanova, Pennsylvania; ‡Department of Anesthesiology, University of Miami, Miami, Florida; §Pediatric Dental Anesthesiology Associates, Tampa, Florida.
authors.forename: Girish P
authors.initials: GP
authors.lastname: Joshi
authors.forename: Meena S
authors.initials: MS
authors.lastname: Desai
authors.forename: Steven
authors.initials: S
authors.lastname: Gayer
authors.forename: Hector
authors.initials: H
authors.lastname: Vila
mesh_terms: D058109:Airway Management / Q000009:adverse effects / Q000379:methods*; D000553:Ambulatory Care / Q000706:statistics & numerical data*; D000554:Ambulatory Care Facilities; D000758:Anesthesia; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use; D004632:Emergency Medical Services; D006801:Humans; D007826:Laryngismus / Q000188:drug therapy / Q000401:mortality*; D008305:Malignant Hyperthermia / Q000401:mortality*; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000627:therapeutic use; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D019990:Perioperative Care; D015995:Prevalence; D013390:Succinylcholine / Q000009:adverse effects*
chemical_list: D009125:Muscle Relaxants, Central; D009467:Neuromuscular Depolarizing Agents; D003620:Dantrolene; D013390:Succinylcholine